Success Story: Biotechnology Researcher Secures I-140 EB-1B Approval in Just 14 Days for Work Advancing Scalable Bioprocessing

Client’s Testimonial:

 

"Great experience working with Chen Immigration Attorneys!”

 


 

On May 7th, 2026, we received another EB-1B (Outstanding Professors and Researchers) approval for a Scientist in the Field of Biotechnologies (Approval Notice).

 


 

General Field: Biotechnologies

 

Position at the Time of Case Filing: Scientist

 

Country of Origin: India

 

State of Residence at the Time of Filing: California

 

Approval Notice Date: May 7th, 2026

 

Processing Time: 14 days (Premium Processing Requested)

 


 

Case Summary:

 

We are pleased to share an I-140 EB-1B approval for a biotechnology researcher whose work focuses on scalable downstream bioprocessing strategies for extracting, recovering, and purifying high-value biomolecules. Filed with direct Premium Processing at the time of submission, the petition was approved in just 14 days.

 

The client holds a Ph.D. and an M.S. in biological and agricultural engineering and is currently employed as a senior scientist in downstream process development. In this role, the client develops robust and scalable purification processes for biologics intended for manufacturing, including work involving technology transfer, manufacturing readiness, and process compliance. This employment helped support the petition’s argument that the client has a qualifying permanent research role and is continuing to apply her specialized expertise in the United States.

 

The client’s record of achievement included the following evidence:

 

  • 6 peer-reviewed journal articles

 

  • 4 first-authored journal articles

 

  • 2 first-authored peer-reviewed conference articles

 

  • 2 conference abstracts, including 1 first-authored abstract

 

  • 175 citations to the client’s published work

 

  • At least 17 completed peer reviews

 

  • National Science Foundation-supported research

 

The petition was also supported by 4 letters of recommendation from experts in the field, including independent experts who were familiar with the client’s work through published research. These letters helped explain how the client’s bioprocessing methods contributed to the recovery of pigments, proteins, therapeutic biomolecules, and fatty acids, and how her work supports scalable biotechnology and biopharmaceutical production.

 

“Without a doubt, she is a talented scientist whose research is essential to enhancing the bioprocessing of valuable products.”

 

Overall, the petition established that the client’s publication record, citation impact, peer-review service, funding evidence, expert letters, research experience, and qualifying employment collectively supported classification as an outstanding researcher. We congratulate the client on this I-140 EB-1B approval and wish her continued success in advancing scalable bioprocessing technologies that support more reliable and cost-effective biotechnology and biopharmaceutical manufacturing.